Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Academic Article uri icon

Overview

abstract

  • A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

authors

  • Kamboj, Mini
  • Son, Crystal
  • Cantu, Sherry
  • Chemaly, Roy F
  • Dickman, Jeanne
  • Dubberke, Erik
  • Engles, Lisa
  • Lafferty, Theresa
  • Liddell, Gale
  • Lesperance, Mary Ellen
  • Mangino, Julie E
  • Martin, Stacy
  • Mayfield, Jennie
  • Mehta, Sapna A
  • O'Rourke, Susan
  • Perego, Cheryl S
  • Taplitz, Randy
  • Eagan, Janet
  • Sepkowitz, Kent Arthur

publication date

  • September 24, 2012

Research

keywords

  • Clostridioides difficile
  • Clostridium Infections
  • Cross Infection
  • Hematopoietic Stem Cell Transplantation
  • Neoplasms

Identity

PubMed Central ID

  • PMC3670420

Scopus Document Identifier

  • 84867465834

Digital Object Identifier (DOI)

  • 10.1086/668023

PubMed ID

  • 23041818

Additional Document Info

volume

  • 33

issue

  • 11